BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23678154)

  • 1. Serum urate and incidence of kidney disease among veterans with gout.
    Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu E; Tawk RH; Liu J; Shi L
    J Rheumatol; 2013 Jul; 40(7):1166-72. PubMed ID: 23678154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout.
    Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu EQ; Tawk R; Liu J; Shi L
    QJM; 2013 Aug; 106(8):721-9. PubMed ID: 23620537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kidney in hyperuricemia and gout.
    Mount DB
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study.
    Chen JH; Pan WH; Hsu CC; Yeh WT; Chuang SY; Chen PY; Chen HC; Chang CT; Huang WL
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):133-40. PubMed ID: 22933424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?
    Wu EQ; Patel PA; Mody RR; Yu AP; Cahill KE; Tang J; Krishnan E
    J Rheumatol; 2009 May; 36(5):1032-40. PubMed ID: 19369467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.
    Dalbeth N; Phipps-Green A; Frampton C; Neogi T; Taylor WJ; Merriman TR
    Ann Rheum Dis; 2018 Jul; 77(7):1048-1052. PubMed ID: 29463518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
    Levy GD; Rashid N; Niu F; Cheetham TC
    J Rheumatol; 2014 May; 41(5):955-62. PubMed ID: 24692523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study.
    Krishnan E
    Arthritis Rheum; 2013 Dec; 65(12):3271-8. PubMed ID: 23982888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data.
    Essex MN; Hopps M; Bienen EJ; Udall M; Mardekian J; Makinson GT
    J Clin Rheumatol; 2017 Apr; 23(3):160-166. PubMed ID: 28248798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index.
    Reynolds RJ; Vazquez AI; Srinivasasainagendra V; Klimentidis YC; Bridges SL; Allison DB; Singh JA
    Rheumatol Int; 2016 Feb; 36(2):263-70. PubMed ID: 26427508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level lead exposure and the prevalence of gout: an observational study.
    Krishnan E; Lingala B; Bhalla V
    Ann Intern Med; 2012 Aug; 157(4):233-41. PubMed ID: 22910934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
    Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
    J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia in patients with chronic plaque psoriasis.
    Gisondi P
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S70-2. PubMed ID: 25381984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
    Baker JF; Schumacher HR; Krishnan E
    Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum urate levels and gout flares: analysis from managed care data.
    Sarawate CA; Patel PA; Schumacher HR; Yang W; Brewer KK; Bakst AW
    J Clin Rheumatol; 2006 Apr; 12(2):61-5. PubMed ID: 16601538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review.
    Shiozawa A; Szabo SM; Bolzani A; Cheung A; Choi HK
    J Rheumatol; 2017 Mar; 44(3):388-396. PubMed ID: 28148699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.